• 1
    Meissner HI, Rimer BK, Davis WW, Eisner E, Siegler IC. Another round in the mammography controversy. J Womens Health. 2003; 12: 1-16.
  • 2
    Olsen O, Gotzsche PC. Cochrane Review on screening for breast cancer with mammography. Lancet. 2001; 358: 1340-1342.
  • 3
    The Editors. When evidence collides with anecdote, politics, and emotion: breast cancer screening. Ann Intern Med. 2010; 152: 531-532.
  • 4
    Meissner HI, Smith RA, Rimer BK, et al. Promoting cancer screening: learning from experience. Cancer. 2004; 101( suppl 5): 1107-1117.
  • 5
    Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst. 1993; 85: 1644-1656.
  • 6
    National Institutes of Health, Consensus Development Panel. National Institutes of Health consensus development conference statement: breast cancer screening for women ages 40-49, January 21-23, 1997. J Natl Cancer Inst. 1997; 89: 1015-1026.
  • 7
    US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009; 151: 716-726.
  • 8
    Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin. 2003; 53: 141-169.
  • 9
    ACOG Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin Number 42: breast cancer screening. ACOG Pract Bull. 2003; 101: 821-831.
  • 10
    Ryerson AB, Miller JW, Eheman CR, Leadbetter S, White MC. Recent trends in US mammography use from 2000-2006: a population-based analysis. Prev Med. 2008; 47: 477-482.
  • 11
    Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J. The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol Assess. 2000; 4: 1-133.
  • 12
    Klabunde CN, O'Malley MS, Kaluzny AD. Physicians' reactions to change in recommendations for mammography screening. Am J Prev Med. 1997; 13: 432-438.
  • 13
    Saint M, Gildengorin G, Sawaya GF. Current cervical neoplasia screening practices of obstetrician/gynecologists in the US. Am J Obstet Gynecol. 2005; 192: 414-421.
  • 14
    Yabroff K, Saraiya M, Meissner H, et al. Specialty differences in primary care physician reports of Papanicolaou test screening practices: a national survey, 2006 to 2007. Ann Intern Med. 2009; 151: 602-611.
  • 15
    Nadel M, Berkowitz Z, Klabunde C, Smith R, Coughlin S, White M. Fecal occult blood testing beliefs and practices of US primary care physicians: serious deviations from evidence-based recommendations. J Gen Intern Med. 2010; 25: 833-839.
  • 16
    American Cancer Society. 1989 Survey of physicians' attitudes and practices in early cancer detection. CA Cancer J Clin. 1990; 40: 77-101.
  • 17
    Klabunde C, Frame PS, Meadow A, Jones E, Nadel M, Vernon SW. A national survey of primary care physicians' colorectal cancer screening recommendations and practices. Prev Med. 2003; 36: 352-362.
  • 18
    Research Triangle Institute. SUDAAN User's Manual, Release 9.0.1. Research Triangle Park, NC: Research Triangle Institute; 2005.
  • 19
    US Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med. 2002; 137: 344-346.
  • 20
    Han PKJ, Kobrin SC, Klein WMP, Davis WW, Stefanek M, Taplin SH. Perceived ambiguity about screening mammography recommendations: association with future mammography uptake and perceptions. Cancer Epidemiol Biomarkers Prev. 2007; 16: 458-466.
  • 21
    Elmore JG, Taplin SH, Barlow WE, et al. Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammography. Radiology. 2005; 236: 37-46.
  • 22
    Berlin L. Breast cancer, mammography, and malpractice litigation: the controversies continue. Am J Roentgenol. 2003; 180: 1229-1237.
  • 23
    Haggerty J, Tudiver F, Brown J, Herbert C, Ciampi A, Guibert R. Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests. Cancer Fam Physician. 2005; 51: 1659.
  • 24
    Qaseem A, Snow V, Sherif K, et al. Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007; 146: 511-515.
  • 25
    Nutting PA, Baier M, Werner JJ, Cutter G, Conry C, Stewart L. Competing demands in the office visit: what influences mammography recommendations? J Am Board Fam Med. 2001; 14: 352-361.
  • 26
    Bhosle M, Samuel S, Vosuri V, Paskett E, Balkrishnan R. Physician and patient characteristics associated with outpatient breast cancer screening recommendations in the United States: analysis of the National Ambulatory Medical Care Survey Data 1996-2004. Breast Cancer Res Treat. 2007; 103: 53-59.
  • 27
    Lane DS, Caplan LS, Grimson R. Trends in mammography use and their relation to physician and other factors. Cancer Detect Prev. 1996; 20: 332-341.
  • 28
    Lafata JE, Simpkins J, Lamerato L, Poisson L, Divine G, Johnson CC. The economic impact of false-positive cancer screens. Cancer Epidemiol Biomarkers Prev. 2004; 13: 2126-2132.
  • 29
    Lipkus I, Halabi S, Strigo T, Rimer BK. The impact of abnormal mammograms on psychosocial outcomes and subsequent screening. Psychooncology. 2000; 9: 402-410.
  • 30
    Swan J, Breen N, Graubard BI, et al. Data and trends in cancer screening in the United States. Cancer. 2010; 116: 4872-4881.
  • 31
    Peres J. Mammography screening: after the storm, calls for more personalized approaches. J Natl Cancer Inst. 2010; 102: 9-11.